Mitchell C. Posner to Camptothecin
This is a "connection" page, showing publications Mitchell C. Posner has written about Camptothecin.
Connection Strength
0.064
-
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
Score: 0.036
-
Phase II study of topotecan in metastatic non-small-cell lung cancer. J Clin Oncol. 1994 Feb; 12(2):347-52.
Score: 0.028